#United States #Life Sciences #Advancion Corporation #MOPS Buffer #Sterlington

Advancion Advances U.S. Manufacturing

Advancion Corporation, a key player in the life sciences sector, has taken a significant leap forward by announcing the launch of its commercial MOPS buffer production at its state-of-the-art facility in Sterlington, Louisiana, as of October 2, 2025. This strategic expansion not only elevates Advancion's manufacturing capabilities but also reinforces its commitment to ensuring a reliable supply chain for critical life science ingredients.

MOPS, or 3-(N-morpholino)propanesulfonic acid, is a zwitterionic biological buffer widely utilized in various applications within cell culture and bioprocessing. The buffer is essential for maintaining a stable, near-neutral pH, making it an invaluable asset in processes such as protein purification, electrophoresis, cell lysis, and nucleic acid research. Its low reactivity and minimal interference with biological reactions also render MOPS suitable for diagnostic assays and downstream bioprocessing, where pH stability is paramount for product quality.

Executive Vice President of Global Life Sciences, Liam Doherty, highlighted the significance of this production launch, stating, "The launch of commercial-scale MOPS production is a key step in strengthening Advancion's leadership in life science buffers. Producing MOPS in-house at our Sterlington facility secures a dependable global supply while maintaining the highest standards of quality, purity, and compliance. This expansion underscores our commitment to transparent, reliable buffer manufacturing and to investing in capacity to fuel growth and innovation across the global biopharmaceutical industry."

The introduction of MOPS buffer products aligns with Advancion's stringent Global Quality Management System, which encompasses ISO 9001:2015 certified monitoring and control processes at the facility. Rigorous quality testing is performed using validated analytical methods, ensuring that the products meet the highest standards in the industry. Multi-batch samples of the new MOPS buffers are currently available for customer qualification, allowing partners to assess the product for their specific applications.

For those interested in learning more or ordering samples, they can visit Advancion’s official website at advancionsciences.com/contact or reach out to a Life Sciences representative directly through their contact email for further inquiries.

About Advancion Corporation

Founded over 80 years ago, Advancion Corporation is recognized as one of the largest producers of life sciences buffers and other proprietary specialty ingredients. The company focuses on delivering high-performance products across biotechnology, pharmaceuticals, personal care, and industrial markets, ensuring best-in-class quality and supply security. Advancion operates three manufacturing facilities in the United States and Germany and serves its global customers from regional Customer Application Centers located in major cities, including Chicago, Paris, São Paulo, Singapore, Shanghai, and Mumbai. Currently, the company is privately owned by Ardian and Golden Gate Capital, with its headquarters situated in Buffalo Grove, Illinois. For more information on their products and services, head over to advancionsciences.com. Follow Advancion on LinkedIn to stay updated with their latest innovations and organizational news.

The launch of commercial MOPS buffer production represents a bold move towards securing the supply chain in the life sciences sector, reflecting Advancion's unwavering commitment to quality and reliability in this critical field.